Introduction {#s1}
============

Dendritic spines compartmentalize biochemical reactions that are critical for synaptic plasticity, which underpins memory and learning. A myriad of signaling molecules acts in a spatiotemporally controlled manner to translate the information encoded in post-synaptic calcium influx into appropriate changes in synaptic strength during learning ([@bib53]). A central signaling role in the spine is assumed by the tyrosine kinase Fyn, a member of the Src family, which is widely expressed throughout the brain ([@bib54]). Fyn is myristoylated, a process that occurs co-translationally on free ribosomes, and is subsequently palmitoylated, which enhances the hydrophobicity of the molecule and membrane association ([@bib59]). The synaptic scaffolding protein PSD-95 is also palmitoylated and known to bind membrane-associated Fyn, recruiting it into the proximity of the GluN2B subunit of the NMDA receptor (NMDAR), thereby enhancing Fyn-mediated phosphorylation of GluN2B ([@bib61]). This results in an increased stability of the NMDAR complex at the synaptic membrane, which is critical for synaptic plasticity ([@bib56]).

Fyn acts as a molecular hub that interacts with multiple synaptic proteins and controls major signaling pathways ([@bib53]). A functional role for Fyn in the dendritic compartment is underscored by the finding that Fyn knockout mice exhibit a decreased spine density in layer V pyramidal neurons ([@bib51]), reduced axonal branching in the cerebellar cortex ([@bib10]), and deficits in long-term potentiation and spatial learning ([@bib20]). Fyn requires the microtubule-associated protein Tau, a protein that is implicated in neurodegenerative diseases including Alzheimer\'s disease (AD) and frontotemporal dementia (FTD), for its efficient targeting to the dendritic compartment ([@bib28]; [@bib68]). This process is facilitated by the interactions of Tau with the SH3 domain of Fyn and of tyrosine-phosphorylated Tau with the SH2 domain of Fyn ([@bib42]; [@bib3]). Further, increased Tau expression (in particular that of mutant Tau forms found in FTD, such as P301L Tau) is associated with increased synaptic localization, not only of Tau but also of Fyn ([@bib28]; [@bib68]; [@bib23]).

Fyn acts as a key mediator of two central molecules in AD, amyloid-β (Aβ) and Tau, which forms amyloid plaques and neurofibrillary tangles, respectively, with Aβ lying upstream of Tau in the pathocascade ([@bib18]). Aβ acts on Fyn via multiple receptors that are located on the plasma membrane, including the prion protein PrP^c^ ([@bib63]; [@bib41]; [@bib64]). Activated Fyn phosphorylates NMDARs and mediates interactions between NMDAR and PSD-95, which are required for Aβ-induced excitotoxicity ([@bib63]). Fyn further mediates Aβ-induced local protein translation and the accumulation of Tau in the somatodendritic compartment by activating the ERK/rpS6 signaling pathway ([@bib46]). Fyn overexpression also accelerates cognitive impairment ([@bib9]; [@bib36]), whereas depleting Fyn or inhibiting its activity restores memory function and synaptic density in AD model mice ([@bib8]). Therefore, both Aβ toxicity and Tau pathology involve Fyn kinase activity ([@bib29]; [@bib21]).

How Fyn integrates these diverse signals in subcellular compartments such as spines is currently unknown. It is difficult to conceive how individual Fyn molecules can act as a nexus that is capable of integrating such a variety of signals. Whether Fyn is spatiotemporally organized to mediate efficient signal transduction remains to be established. The spatial organization of receptors and signaling molecules into nanodomains in biological membranes is emerging as an essential feature of cell signaling ([@bib40]). These nanodomains are formed by a combination of protein--protein, lipid--lipid, protein--lipid and cytoskeletal interactions ([@bib50]; [@bib19]; [@bib55]), as well as by membrane-mediated forces ([@bib34]). Consequently, these nanodomains concentrate various molecules in discrete areas, thereby facilitating efficient and robust processing of cellular information by regulating a complex series of biochemical reactions ([@bib22]). Indeed, a recent study has demonstrated that ligand-induced CD36 receptor clustering promotes Fyn activation within these clusters in non-neuronal cells ([@bib16]). Whether Fyn concentrates in such nanodomains in the dendrites, and whether Tau regulates the nanoscale organization of Fyn, is not known but such mechanisms could underlie the pleiotropic roles that Fyn assumes in neuronal signaling.

The advent of super-resolution microscopy has paved the way for investigations of the nanoscale organization and dynamic behavior of receptors ([@bib52]; [@bib24]), as well as for studies on their signaling ([@bib48]), trafficking ([@bib32]) and scaffolding molecules ([@bib6]). Here, we used single-particle tracking photoactivated localization microscopy (sptPALM) to determine whether Tau controls the organization of Fyn in the somatodendritic compartment. We found that dendritic Fyn displayed a nanocluster organization that is underpinned by multiple mobility states, and that Fyn mobility significantly decreased in dendrites with neuronal maturation. In neurons from Tau knockout (Tau KO) mice, Fyn mobility increased in the dendritic shafts, an effect that was rescued by the re-expression of wildtype (WT) Tau. More importantly, pathological P301L mutant Tau, as found in familial FTD, but not a truncated form of Tau lacking the microtubule-binding domain (ΔTau), promoted the trapping of Fyn in the dendritic spines. Our study therefore reveals a complex interplay between Fyn and Tau in the somatodendritic compartment and points to a novel role of altered Fyn nanoclustering in causing synaptic dysfunction in disease.

Results {#s2}
=======

sptPALM reveals changes in the dendritic nanoscale organization of Fyn as neurons mature {#s2-1}
----------------------------------------------------------------------------------------

To investigate the spatial distribution and mobility pattern of the kinase Fyn in live neurons, we fused Fyn with the photoconvertible fluorescent protein mEos2 (Fyn-mEos2), and expressed this fusion protein in hippocampal neurons obtained from WT mice. We then performed sptPALM, using mCardinal as a cytoplasmic marker ([Figure 1a,b](#fig1){ref-type="fig"}). We used an oblique illumination configuration to image the dendrites of neurons at a stage when they predominantly exhibited filopodia (11--15 days in vitro (DIV)) and when they had developed mature spines (DIV19-20) ([Figure 1a--d](#fig1){ref-type="fig"}). By applying a weak intensity 405 nm laser, Fyn-mEos2 molecules were randomly photoconverted from a green- to a red-emitting state at a low spatial density, such that individual Fyn-mEos2 molecules could be correctly localized and tracked. The photoconverted molecules were then detected in the red-emitting channel at 561 nm excitation at 50 Hz for a duration of 320 s (16,000 frames), allowing for the characterization of Fyn distribution in live neurons at a high spatiotemporal resolution.

![Fyn mobility decreases with dendritic spine maturation.\
The analysis was performed at days in vitro (DIV)11--15 and DIV19--20. (**a--d**) Representative epifluorescence images of DIV12 (**a, c**) and DIV20 (**b, d**) neurons co-expressing mCardinal (**a, b**) and Fyn-mEos2 (**c, d**), acquired before photoconversion of mEos2 molecules. Insets are shown at a higher magnification. Scale bars, 1 μm. (**e--j**) sptPALM imaging was performed at 50 Hz for 320 s (16,000 frames) to construct the maps of the localization intensities (**e, f**), diffusion coefficients (**g, h**) and trajectories (**i, j**) of Fyn-mEos2 molecules. The cooler colors represent higher localization intensities (**e, f**) and larger diffusion coefficients (**g, h**), and each trajectory is coded with a different color (**i, j**). (**k--n**) Comparison of Fyn mobility parameters with development. (**k**) Average mean square displacement (MSD) as a function of time. (**l**) The corresponding area under the MSD curves (AUC). (**m**) Distribution of diffusion coefficients (**D**) shown in a semi-log plot. The threshold to distinguish the immobile (Log~10~\[D\]≤−1.6) and the mobile (Log~10~\[D\]\>−1.6) fraction of molecules is indicated with a dashed line. (**n**) The corresponding immobile fraction. Error bars are standard errors of the mean (SEM). Mean ± SEM values were obtained from n = 31 neurons (DIV11--15) and n = 14 neurons (DIV19--20). Statistical comparisons were performed using the Mann-Whitney U test (**l**) and Student's *t*-test (**n**).](elife-45040-fig1){#fig1}

The low-resolution epifluorescence image of Fyn-mEos2 suggested a relatively uniform distribution of Fyn in the dendrites, whereas the sptPALM localization density map, which was generated by binning all the localizations acquired over the 16,000 frames, revealed a very heterogeneous spatial distribution of localization densities in dendrites and even within individual spines ([Figure 1e,f](#fig1){ref-type="fig"}). Regions with high localization density tended to have a higher local concentration of Fyn molecules than regions with low localization density ([@bib11]), suggesting the presence of Fyn-enriched nanodomains in dendrites. Nanodomains generally stem from the lateral trapping of molecules in discrete areas of the plasma membrane. We therefore computed the trajectories of Fyn-mEos2 molecules lasting for at least eight frames and generated a spatial map of diffusion coefficients, with Fyn mobility values being directly proportional to the diffusion coefficients ([Figure 1g,h](#fig1){ref-type="fig"}). We found that Fyn mobility was spatially heterogeneous and that the diffusion coefficients of Fyn-mEos2 molecules varied more than 100-fold in individual neurons and even within individual spines ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Using a Voronoï-tessellation-based spatial clustering algorithm ([@bib44]), we identified potential Fyn nanodomains (or nanoclusters) within spines and estimated the diameter of these nanodomains to be \~168.3 ± 4.2 nm (mean ± SEM; n = 502 nanodomains; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). This is comparable to the size of PSD-95 nanodomains in spines measured using sptPALM ([@bib52]) and is around three times smaller than the size of a spine head ([@bib30]). These results establish the existence of discrete Fyn nanodomains in the somatodendritic compartment, and highlight the capability of sptPALM in examining single-molecule and population-level dynamics of Fyn molecules in individual cells at high resolution.

Given that Fyn has a critical role in integrating signaling pathways in the dendritic compartment ([@bib46]), we next investigated whether the mobility of Fyn changes during maturation by analyzing filopodia-forming DIV11-15 neurons and spine-forming DIV19-20 neurons. First, we computed the mean square displacement (MSD) of individual trajectories lasting for at least eight frames, and then calculated the average of the MSDs of all trajectories from each analyzed cell ([Figure 1k](#fig1){ref-type="fig"}). We used the area under the average MSD curve (AUC) of each cell for statistical comparisons ([Figure 1l](#fig1){ref-type="fig"}). We then estimated the diffusion coefficients from the MSDs of each trajectory and generated a frequency distribution of the diffusion coefficients of all trajectories from each analyzed neuron ([Figure 1m](#fig1){ref-type="fig"}). The distributions of the diffusion coefficients were then grouped into two fractions, immobile and mobile, on the basis of a threshold value of the diffusion coefficient, as described previously ([@bib12]) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), with the immobile fraction being used for statistical comparisons ([Figure 1n](#fig1){ref-type="fig"}). We detected Fyn-mEos2 molecules in both the spines and shaft regions at both time points of maturation ([Figure 1e--j](#fig1){ref-type="fig"}), and noted a frequent exchange of Fyn-mEos2 molecules between these two compartments. Interestingly, we found that the average MSD and AUC decreased and the immobile fraction increased significantly with dendritic maturation, and that the frequency distribution of diffusion coefficients shifted to the left with dendritic maturation, demonstrating that Fyn mobility decreased as dendrites matured. These observations suggest that the extent of lateral trapping of Fyn in dendrites increases with neuronal development and spine maturation, possibly reflecting the dynamic changes in the composition of Fyn-binding partners in dendrites.

Fyn mobility is lower in spines than in dendritic shafts {#s2-2}
--------------------------------------------------------

Fyn has multiple substrates in the dendritic compartment, including Tau ([@bib28]), PSD-95 ([@bib67]), and Pyk2 ([@bib47]). These proteins are also binding partners of Fyn, with their abundance and composition likely to be spatially regulated in the shafts and spines. For instance, it has been reported that PSD-95 is enriched in spines, whereas Tau levels in this compartment are low unless the protein either carries a pathological mutation found in familial cases of FTD or is hyperphosphorylated ([@bib23]). To investigate whether Fyn mobility differs between the dendritic shafts and spines of hippocampal neurons (DIV20-22), we co-expressed Fyn-mEos2 and enhanced green fluorescence protein (EGFP) as a volume marker to identify each compartment, and compared the mobility of Fyn-mEos2 in dendritic shafts and spines. We first acquired image stacks of the epifluorescence GFP signal, which allowed us to create a three-dimensional (3D) reconstruction of the dendritic structure ([Figure 2a--c](#fig2){ref-type="fig"}). We then performed sptPALM of Fyn-mEos2. Only spines protruding from the sides of the dendrite branch were considered in our analysis ([Figure 2a--c](#fig2){ref-type="fig"}), with trajectories being extracted from these spines (color-coded in blue in [Figure 2d](#fig2){ref-type="fig"}). We next identified trajectories from the dendritic shaft region (color-coded in red in [Figure 2d](#fig2){ref-type="fig"}) by excluding the shaft segments containing spines projecting away from the imaging plane (white arrows in [Figure 2b,c](#fig2){ref-type="fig"} and black arrows in [Figure 2d](#fig2){ref-type="fig"}). This procedure allowed us to compare Fyn mobility in the dendritic shafts and spines for every analyzed cell. Remarkably, we found that the mobility of Fyn-mEos2 was significantly lower in the spines than in the shafts, as assessed by changes in the average MSD ([Figure 2e](#fig2){ref-type="fig"}), the AUC ([Figure 2f](#fig2){ref-type="fig"}), the distribution of diffusion coefficients ([Figure 2g](#fig2){ref-type="fig"}) and the immobile fraction ([Figure 2h](#fig2){ref-type="fig"}). These results suggest a higher abundance of binding partners or sites for Fyn in spines than in dendritic shafts.

![Fyn mobility is lower in spines than in shafts.\
(**a**) An EGFP image stack of a representative hippocampal neuron co-expressing Fyn-mEos2 and EGFP is shown as a two-dimensional (2D) maximum intensity projection along the z-direction. (**b**) 3D reconstruction of the same neuron using Neurolucida. (**c**) The image shown in (b) rotated 180° along the y-axis. (**d**) Trajectories belonging to spines that were nearly parallel to the sptPALM imaging plane (blue) and the dendritic shaft region (red) of the same neuron shown in (a). Dendritic segments containing spines projecting away from the sptPALM imaging plane were discarded (white arrows in (b) and (c), and black arrows in (d)). (**e--h**) Comparison of Fyn mobility parameters in dendritic shafts and spines. (**e**) Average mean square displacement (MSD) as a function of time. (**f**) The corresponding area under the MSD curves (AUC). (**g**) The distribution of diffusion coefficients (D) shown in a semi-log plot. The threshold used to distinguish the immobile (Log~10~\[D\]≤−1.6) and mobile (Log~10~\[D\]\>−1.6) fractions of molecules is indicated with a dashed line. (**h**) The corresponding immobile fractions. Error bars are SEM. Mean ± SEM values were obtained from n = 12 neurons. Statistical comparisons were performed using a paired Student's *t*-test (**f, h**).](elife-45040-fig2){#fig2}

Fyn exhibits multiple kinetic subpopulations within shafts and spines {#s2-3}
---------------------------------------------------------------------

To further characterize Fyn mobility patterns in dendritic shafts and spines, we first performed a moment scaling spectrum (MSS) analysis of Fyn trajectories that lasted for at least 20 frames (0.4 s) and estimated the slope of the MSS (S~MSS~). The MSS analysis revealed that Fyn-mEos2 molecules exhibit at least three different motion types in spines and shafts: immobile, confined and free diffusive states ([Figure 3a](#fig3){ref-type="fig"}). Trajectories with an S~MSS~ close to 0 represent immobile molecules, those with an S~MSS~ between 0 and 0.5 represent confined molecules, and those with an S~MSS~ close to 0.5 represent apparently free molecules. We next analyzed the cumulative distribution of displacements of Fyn-mEos2 molecules at 20 ms intervals by applying a three-diffusive state model, with each state being differentiated by its diffusion coefficient. This model provided an excellent fit to the data ([Figure 3b](#fig3){ref-type="fig"}) and yielded estimates of apparent diffusion coefficients and state occupancies for each state, with the latter representing the fraction of Fyn molecules in each state ([Figure 3c, d](#fig3){ref-type="fig"}). We found that the apparent diffusion coefficients of the three diffusive states were similar in shafts and spines ([Figure 3c](#fig3){ref-type="fig"}), suggesting that similar molecular mechanisms could give rise to different mobility states of Fyn in both compartments. We associated the state with the lowest diffusion coefficient (S~1~) to immobilized Fyn molecules, and the state with the intermediate diffusion coefficient (S~2~) to confined Fyn molecules, both states constituting Fyn molecules within nanodomains. The state with the largest diffusion coefficient (S~3~) represents freely moving Fyn molecules that are found outside nanodomains. Interestingly, the occupancies of the immobile and confined states were significantly higher and the occupancy of the free state significantly lower in the spines compared to shafts ([Figure 3d](#fig3){ref-type="fig"}), suggesting that the exchange between and the retention in different subpopulations of Fyn are differentially regulated in spines and shafts.

![Multiple kinetic populations of Fyn in spines and shafts.\
(**a**) Distribution of the slope of the moment scaling spectrum (S~MSS~) of trajectories lasting for at least 20 frames. (**b**) Representative fit (solid black line) of a three-diffusive-state model ([Equation (1)](#equ1){ref-type="disp-formula"}) of the cumulative distribution of displacements at 20 ms intervals from Fyn-mEos2 molecules located inside the spines and shafts of neurons. The contribution of each diffusive state is shown individually. (**c**) A three-state model in which the estimated apparent diffusion coefficients and state occupancies are represented (state S1, immobile; state S2, confined; state S3, apparently free), with the circle area being proportional to the state occupancy. (**d**) Comparison of the estimated state occupancies of Fyn-mEos2 molecules in spines (blue) and shafts (red). Statistical comparisons were performed using paired Student's *t*-tests .](elife-45040-fig3){#fig3}

Tau controls the nanoscale organization of Fyn in hippocampal dendrites {#s2-4}
-----------------------------------------------------------------------

Given that Tau binds directly to Fyn ([@bib42]; [@bib3]), controls the dendritic targeting of Fyn ([@bib28]) and facilitates the recruitment of Fyn to the PSD-95 complex in spines ([@bib28]), we next investigated whether Tau also controls the nanoscale organization of Fyn in dendrites. Under physiological conditions, Tau is predominantly located in axons, with a smaller fraction of Tau being found in dendritic shafts, and an even smaller fraction in spines. We first confirmed our previous, biochemical finding ([@bib28]) that the dendritic targeting of Fyn is significantly reduced in Tau knock-out (Tau KO) compared to wildtype hippocampal neurons using confocal microscopy. Although the Fyn localization intensity was significantly decreased in the dendrites of Tau KO neurons compared to those of WT neurons, we were still able to observe Fyn localization in both the dendritic shafts and spines of Tau KO neurons, albeit at much lower levels ([Figure 4a--c](#fig4){ref-type="fig"}).

![Loss of Tau reduces the localization of endogenous Fyn into the dendritic arbor.\
Immunocytochemistry of Fyn to characterize the distribution of endogenous Fyn along the dendritic arbor in wildtype (WT) and Tau knock-out (KO) mouse hippocampal neurons. (**a, b**) Panels showing the distribution of Fyn (green) in WT neurons (**a**) and Tau KO neurons (**b**). MAP2 (blue) was used to identify dendrites and PSD-95 (red) was used to identify dendritic spines. (**c**) Quantification of the average intensity of Fyn immunofluorescence in dendrites from WT and Tau KO neurons. Mean ± SEM values are calculated from n = 13 neurons. A statistical comparison of the average intensities was performed using a Student's *t*-test. Scale bars, 20 μm.](elife-45040-fig4){#fig4}

We next performed sptPALM on WT and Tau KO neurons co-expressing Fyn-mEos2 and mCardinal at DIV19--22 and examined the effect of endogenous Tau expression on Fyn mobility ([Figure 5](#fig5){ref-type="fig"}). We detected Fyn-mEos2 molecules in both dendritic shafts and spines, and found that Fyn-mEos2 mobility was spatially heterogeneous in the dendrites of both WT and Tau KO neurons ([Figure 5a--d](#fig5){ref-type="fig"}). Although the mobility of Fyn-mEos2 appeared to be higher in the dendrites of Tau KO neurons compared to those of WT neurons, this difference was not statistically significant when the average MSD ([Figure 5e](#fig5){ref-type="fig"}), the AUC ([Figure 5f](#fig5){ref-type="fig"}), the frequency distribution of diffusion coefficients ([Figure 5g](#fig5){ref-type="fig"}) and the immobile fraction ([Figure 5h](#fig5){ref-type="fig"}) were determined. We then focused explicitly on Fyn in spines and determined whether its mobility was altered in Tau KO compared to WT neurons. This analysis revealed that the average MSD ([Figure 5i](#fig5){ref-type="fig"}) and the frequency distribution of diffusion coefficients ([Figure 5k](#fig5){ref-type="fig"}) were again remarkably similar and that the corresponding AUC ([Figure 5j](#fig5){ref-type="fig"}) and immobile fraction ([Figure 5l](#fig5){ref-type="fig"}) were not significantly different, indicating that the absence of Tau did not affect the nanoscale organization of Fyn in the spines. In other words, although Tau has a role in targeting Fyn to the dendritic compartment ([@bib28]), the nanoscale organization of the fraction of Fyn that entered this compartment was not affected by Tau knockout.

![Loss of Tau alters Fyn mobility in the dendritic shafts but not in the spines.\
(**a--d**) Representative epifluorescence images of WT (**a**) and Tau KO (**c**) neurons co-expressing mCardinal and Fyn-mEos2. sptPALM trajectory maps of Fyn-mEos2 molecules in WT (**b**) and Tau KO (**d**) neurons. Regions marked in (a) and (c) are shown at higher magnification in (b) and (d), respectively. Scale bar, 1 μm. (**e--l**) Comparison of Fyn mobility in dendrites (**e--h**) and in spines (**i--l**) of WT (blue) or Tau KO (red) neurons. Mean ± SEM values were obtained from n = 14 WT neurons and n = 9 Tau KO neurons. (**e, i**) The average mean square displacement (MSD) as a function of time. (**f, j**) The corresponding area under the MSD curves (AUC). (**g, k**) The distribution of diffusion coefficients (**D**) shown in a semi-log plot. The dashed line distinguishes the immobile and mobile fractions. (**h, l**) The corresponding immobile fraction. (**m**) Examples of trajectories of Fyn-mEos2 molecules in an individual spine (blue) and the immediately adjacent shaft region (red) of WT (left), Tau KO (middle) and Tau KO expressing TauWT-GFP neurons. Scale bar, 1 μm. (**n**) Effective diffusion coefficients (D~eff~) of the trajectories belonging to individual spines of WT, Tau KO and Tau KO + TauWT neurons. (**o**) D~eff~ of the trajectories belonging to individual shaft regions of WT, Tau KO and Tau KO + TauWT neurons. In (n) and (o), spines or shaft segments that contained at least 50 trajectories were used to compute D~eff~. Statistical comparisons were performed using Student's *t*-test (f, h, j, l) or Kruskal-Wallis test with Dunn's post hoc multiple comparisons test (n, o) . The adjusted p-values accounting for multiple comparisons are reported in (n) and (o).](elife-45040-fig5){#fig5}

We then asked whether the absence of Tau affected Fyn mobility in the dendritic shafts. To investigate this, we identified shaft segments that were immediately adjacent to the spines and computed the effective diffusion coefficient (D~eff~) of Fyn trajectories belonging to each spine and the corresponding shaft segment ([Figure 5m--o](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). The D~eff~ values for individual spines in WT and Tau KO neurons were similar ([Figure 5n](#fig5){ref-type="fig"}), whereas the D~eff~ values for the shaft segments of Tau KO neurons were significantly higher than those of WT neurons ([Figure 5o](#fig5){ref-type="fig"}), suggesting that dendritic Tau regulates the nanoscale organization of Fyn in the shafts from which spines protrude. To determine whether the expression of Tau in Tau KO neurons can rescue this effect on Fyn mobility, we performed sptPALM of Tau KO neurons co-expressing Fyn-mEos2, mCardinal and TauWT-GFP ([Figure 5m--o](#fig5){ref-type="fig"}). As expected, the D~eff~ values of Fyn in the shaft segments of Tau KO neurons expressing TauWT-GFP were not significantly different from those of WT neurons ([Figure 5o](#fig5){ref-type="fig"}).

Together, these results demonstrate that Tau regulates the mobility of Fyn in dendritic shafts, but not in spines, under physiological conditions. The increased trapping of Fyn in the shaft may contribute to the Tau-mediated dendritic targeting of Fyn.

FTD-linked P301L mutant Tau traps Fyn in dendrites {#s2-5}
--------------------------------------------------

Under disease conditions such as AD, Tau accumulates in spines. This has also been shown for Tau carrying the P301L mutation found in familial cases of FTD, which mislocalizes to dendritic spines ([@bib68]; [@bib23]) and has an increased affinity towards Fyn in vitro ([@bib3]). Caspase-2 cleavage of Tau at asparagine 314 (Asp314) and the consequent formation of the truncation product ΔTau314 contributes to the mislocalization of pathological forms of Tau to dendritic spines ([@bib71]). However, the physiological significance of Tau mutant mislocalization and its effect on Fyn nanoclustering is currently not known. We therefore investigated whether the P301L mutant Tau affects the nanoscale organization of Fyn in dendrites, compared to that of WT Tau, by carrying out sptPALM on Tau KO neurons co-expressing Fyn-mEos2, mCardinal and either TauWT-GFP ([Figure 6a](#fig6){ref-type="fig"}) or TauP301L-GFP ([Figure 6b](#fig6){ref-type="fig"}). We found that Fyn mobility dramatically decreased in the dendrites of Tau KO neurons expressing TauP301L-GFP compared to those expressing TauWT-GFP, as evidenced by the changes in the average MSD ([Figure 6c](#fig6){ref-type="fig"}), the AUC ([Figure 6d](#fig6){ref-type="fig"}), the frequency distribution of diffusion coefficients ([Figure 6e](#fig6){ref-type="fig"}), and the immobile fraction ([Figure 6f](#fig6){ref-type="fig"}). We then identified trajectories from spines and determined whether P301L mutant Tau altered the mobility and nanoscale organization of Fyn in these regions. We found that the mobility of Fyn decreased significantly in the spines of Tau KO neurons expressing TauP301L-GFP compared to those expressing TauWT-GFP, as assessed by the changes in the average MSD ([Figure 6g](#fig6){ref-type="fig"}), the AUC ([Figure 6h](#fig6){ref-type="fig"}), the frequency distribution of diffusion coefficients ([Figure 6i](#fig6){ref-type="fig"}), and the immobile fraction ([Figure 6j](#fig6){ref-type="fig"}). These results demonstrate a strong effect of P301L mutant Tau expression on Fyn mobility, and suggest for the first time that the complex interaction dynamics between Tau and Fyn underpin the nanoscale organization of Fyn in the dendritic shaft under physiological conditions and in spines under pathological conditions.

![P301L mutant Tau lowers Fyn mobility in dendrites.\
(**a, b**) Representative low-resolution and super-resolution images of Tau KO neurons expressing mCardinal, Fyn-mEos2 and TauWT-GFP or TauP301L-GFP, obtained using sptPALM. sptPALM imaging was performed at 50 Hz for 320 s (16,000 frames) to construct the maps of localization intensities, diffusion coefficients, and trajectories of Fyn-mEos2 molecules. The cooler colors represent higher localization intensities and larger diffusion coefficients, and each trajectory is coded with a different color. (**c--j**) Comparison of Fyn mobility in the dendrites (**c--f**) and spines (**g--j**) of Tau KO neurons expressing TauWT-GFP (blue) or TauP301L-GFP. (**c, g**) The average mean square displacement (MSD) as a function of time. (**d, h**) The corresponding area under the MSD curves (AUC). (**e, i**) The distribution of diffusion coefficients (D) shown in a semi-log plot. The threshold used to distinguish the immobile (Log~10~\[D\] ≤ −1.6) and mobile (Log~10~\[D\] \> −1.6) fractions of molecules is indicated with a dashed line. (**f, j**) The corresponding immobile fraction. Mean ± SEM values were obtained from n = 11 Tau KO neurons expressing TauWT-GFP and n = 9 Tau KO neurons expressing TauP301L-GFP. Statistical comparisons were performed using Student's *t*-tests (d, f, h, and j).](elife-45040-fig6){#fig6}

FTD-linked P301L mutant Tau immobilizes Fyn in spines {#s2-6}
-----------------------------------------------------

P301L mutant Tau mislocalizes to dendritic spines and impairs spine function ([@bib23]). In order to further dissect the effect of P301L mutant Tau on the organization of Fyn within individual spines, we computed the average MSD and D~eff~ value of trajectories belonging to individual spines of Tau KO neurons expressing either TauWT-GFP or TauP301L-GFP. This analysis revealed that the average MSD and D~eff~ value were significantly lower in individual spines of Tau KO neurons expressing TauP301L-GFP than in those expressing TauWT-GFP ([Figure 7a,b](#fig7){ref-type="fig"}), further supporting our earlier findings ([Figure 6g--6j](#fig6){ref-type="fig"}). We then performed an MSS analysis of Fyn trajectories (see [Figure 3](#fig3){ref-type="fig"}). The S~MSS~ computed from the spine trajectories of Tau KO neurons expressing TauP301L-GFP (mean S~MSS~ = 0.1) was found to be significantly lower than that of Tau KO neurons expressing TauWT-GFP (mean S~MSS~ = 0.13), indicating that Fyn molecules are more confined in the spines of Tau KO neurons expressing P301L mutant Tau ([Figure 7c](#fig7){ref-type="fig"}). We also analyzed the cumulative distribution of displacements of Fyn-mEos2 molecules at 20 ms intervals by applying the three-diffusive-state model ([Figure 7d--e](#fig7){ref-type="fig"}). We found that, although the apparent diffusion coefficients of each state were similar ([Figure 7d](#fig7){ref-type="fig"}), the state occupancy of the immobile state was not significantly different, the state occupancy of the confined state increased and that of the free state significantly decreased in spines of Tau KO neurons expressing TauP301L-GFP when compared to those expressing TauWT-GFP ([Figure 7e](#fig7){ref-type="fig"}). Finally, using a Voronoï-tessellation-based spatial clustering algorithm ([@bib44]), we computed the nanodomain diameter and area, as well as the number of nanodomains per spine. The nanodomain diameter and area were not significantly different between the two conditions, but the number of nanodomains per spine increased in Tau KO neurons expressing TauP301L-GFP when compared to those expressing TauWT-GFP ([Figure 7f--h](#fig7){ref-type="fig"}). To test whether the effect of P301L mutant Tau depends on the increased translocation of Tau into dendritic spines, we performed sptPALM of Fyn on Tau KO neurons expressing Fyn-mEos2, GFP and either TauWT-GFP or Tau lacking the microtubule-binding domain (ΔTau-GFP) that is known to access spines ([@bib28]; [@bib13]). We found that ΔTau-GFP mislocalized to dendritic spines ([Figure 8a](#fig8){ref-type="fig"}) but did not alter Fyn mobility in dendrites ([Figure 8b--e](#fig8){ref-type="fig"}) or spines ([Figure 8f--m](#fig8){ref-type="fig"}). Taken together, these results provide strong evidence that P301L mutant Tau confines Fyn and alters its nanoscale organization within individual spines, demonstrating that Tau acts as a key regulator of Fyn in both physiological and pathological situations.

![Expression of mutant Tau-P301L traps Fyn in spines.\
(**a**) The average mean square displacement (MSD) of Fyn-mEos2 trajectories from individual spines of Tau KO neurons expressing TauWT-GFP (n = 76 spines) or TauP301L-GFP (n = 124 spines). (**b**) The effective diffusion coefficient computed from the MSD of individual spines. (**c**) Distribution of the moment scaling spectrum slope (S~MSS~) of trajectories lasting for at least 20 frames (n = 2282 trajectories from the spines of 11 Tau KO neurons expressing TauWT-GFP and n = 3764 trajectories from the spines of 9 Tau KO neurons expressing TauP301L-GFP). (**d**) A three-state model showing the inferred apparent diffusion coefficients and state occupancies (state S1, immobile; state S2, confined; state S3, apparently free), with the circle area being proportional to the state occupancy. (**e**) Comparison of the estimated state occupancies. (**f, g**) Comparison of average nanodomain diameter (**f**) and area (**g**). (**h**) Comparison of the number of nanodomains per spine. Statistical comparisons were performed using the Kruskal-Wallis test (**b**), the Kolmogorov-Smirnov test (**c**) or Student's *t*-test (**e--h**).](elife-45040-fig7){#fig7}

![Tau lacking the microtubule-binding domain (ΔTau) mislocalizes to dendritic spines but does not affect Fyn mobility in dendrites and spines.\
(**a**) Representative epifluorescence images of Tau KO neurons co-expressing either full-length Tau (TauWT-GFP) and mCardinal or Tau lacking the microtubule-binding domain (ΔTau-GFP) and mCardinal. Arrows denote reduced localization of TauWT-GFP in dendritic spines and arrowheads denote increased mislocalization of ΔTau-GFP in dendritic spines. Scale bar, 1 μm. (**b--i**) Comparison of Fyn mobility in the dendrites (**b--e**) and spines (**f--i**) of Tau KO neurons expressing Fyn-mEos2, TauWT-GFP and GFP (blue) and Tau KO neurons expressing Fyn-mEos2, ΔTau-GFP and GFP. (**b, f**) The average mean square displacement (MSD) as a function of time. (**c, g**) The corresponding area under the MSD curves (AUC). (**d, h**) The distribution of diffusion coefficients (D) shown in a semi-log plot. (**e i,**) The corresponding immobile fraction. (**j**) The average mean square displacement (MSD) of Fyn- mEos2 trajectories from individual spines of Tau KO neurons expressing TauWT-GFP (n = 99 spines) or ΔTau-GFP (n = 181 spines). (**k**) The effective diffusion coefficient computed from the MSD of individual spines. (**l**) The distribution of the moment scaling spectrum slope (S~MSS~) of trajectories lasting for at least 20 frames (n = 2561 trajectories from the spines of 8 Tau KO neurons expressing TauWT-GFP and n = 4943 trajectories from the spines of 11 Tau KO neurons expressing ΔTau-GFP). (**m**) The comparison of the state occupancies estimated using a three-state model. In (b--i) and (m), mean ± SEM values were obtained from n = 8 Tau KO neurons expressing Fyn-mEos2, TauWT-GFP and GFP and n = 11 Tau KO neurons expressing Fyn- mEos2, ΔTau-GFP and GFP. Statistical comparisons were performed using the Mann-Whitney U test (**c, e and k**), Student's *t*-test with Welch's correction (**g, i**), the Kolmogorov-Smirnov test (**l**) and Student's *t*-test (**m**).](elife-45040-fig8){#fig8}

Discussion {#s3}
==========

Signaling mediated through Fyn kinase is critical for synaptic plasticity, and dysregulation of Fyn activity has been implicated in both Aβ and Tau pathology ([@bib29]; [@bib21]). Our study provides the first conceptual framework to describe how the nanoscale organization of Fyn may be essential for synaptic plasticity, with ramifications for Tau-mediated neurodegeneration. We have revealed that Fyn is organized in nanodomains and that its nanoscale organization in dendrites is altered with neuronal maturation, with the kinase being more immobile in dendritic spines compared to shafts. Furthermore, Fyn mobility is characterized by at least three distinct motion states: an immobile, a confined, and a free diffusive state. Importantly, Tau was found to modulate Fyn mobility in dendritic shafts. Although the mutant Tau lacking its microtubule binding domains (ΔTau) did not affect Fyn mobility, the FTD-linked P301L mutant Tau largely increased Fyn trapping in nanodomains in the spines by increasing Fyn occupancy in the confined state and decreasing its occupancy in the free diffusive state. Mutant tau mislocalization into dendritic spines involves the formation of the truncation product ΔTau314, which lacks a part of the microtubule-binding domain as described previously ([@bib71]). Interestingly, tauopathy induced by low levels of truncated Tau can be rescued by pharmacological treatment ([@bib4]). We have previously shown that the expression of P301L mutant Tau increases Fyn levels in PSD fractions ([@bib28]). Here, we show that this synaptic increase in Fyn expression drives aberrant nanoclustering in spines, potentially leading to overactivation of postsynaptic Fyn signaling.

To the best of our knowledge, our study presents the first description of the nanodomain organization of Fyn in dendrites and its regulation by Tau. Understanding the role of Fyn signaling in physiology and pathology is critical, as this kinase acts as a central hub in the integration of multiple neuronal signaling pathways that are dysregulated in disease. Fyn is targeted to dendritic spines by a process that is facilitated by the dual interactions of Tau with the SH3 domain of Fyn and of tyrosine-phosphorylated Tau with the SH2 domain of Fyn ([@bib28]; [@bib43]; [@bib65]). Fyn may therefore regulate some of the functions of Tau in physiology and pathology. Fyn is also a critical mediator of Aβ toxicity. When overexpressed in human Aβ-forming amyloid precursor protein (APP) transgenic mouse models, Fyn accelerates synaptic and cognitive impairment ([@bib9]). Furthermore, synaptic degeneration and memory loss are rescued when either Fyn is depleted or its activity is suppressed in an APP mutant background, such that no Aβ is produced ([@bib36]; [@bib8]). A role for Fyn in mediating the toxicity of oligomeric Aβ through the prion protein PrP^c^ has been demonstrated in cultured neurons and in vivo ([@bib63]; [@bib41]; [@bib64]). Fyn has further been shown to be a critical component of the ERK/rpS6 signaling cascade that facilitates Aβ-mediated increases in Tau levels and phosphorylation ([@bib46]). Other tyrosine kinases from the same Fyn family transduce their nanoclustering membrane organization into efficient downstream signaling during immune cell activation ([@bib58]). Together with the finding that the overexpression of Fyn in the brain causes an excitotoxic phenotype and early lethality ([@bib39]; [@bib69]), our data suggest that the organization of Fyn into nanodomains may allow this kinase to orchestrate multiple signaling pathways by providing a scaffold for diverse signaling components, allowing Fyn to assume a major role in neuronal physiology and pathology. Whether Aβ mediates neurotoxicity by altering Fyn nanodomain organization is currently not known and further research would be required to assess this possibility at the nanoscale level.

The spatial spreading of activated signals from a given spine to a neighboring spine depends on the balance between the diffusion of Fyn and its deactivation rate ([@bib70]). Trapping Fyn in nanodomains limits its diffusion, thereby restricting the kinase\'s signaling to individual spines. By increasing the trapping of Fyn in spines, P301L mutant Tau could potentially promote aberrant Fyn signaling, leading to neurotoxicity and subsequent neuronal degeneration. Interestingly, Fyn-overexpressing mice and patients with FTD exhibit hyperactivity ([@bib69]) and repetitive compulsive behavior ([@bib57]), respectively. This suggests that the neurotoxicity observed in patients could be related to the excessive activity of Fyn, which is promoted by its aberrant Tau-dependent trapping in spines. By trapping Fyn in the shafts, Tau may reduce the flux of Fyn from the dendrite to the soma, which could be one potential mechanism through which Tau restricts Fyn in the dendritic compartment. The trapping of Fyn in the shaft may also limit its access to spines and could therefore fine tune the extent of Fyn clustering and signaling in this essential compartment.

The diffusion coefficients of Fyn varied by at least two orders of magnitude even in the spines of Tau KO neurons, suggesting that several other factors, such as interaction with PSD-95 ([@bib67]), molecular crowding ([@bib45]) and spine geometry ([@bib5]), regulate the trapping and nanodomain organization of Fyn. Recent studies have shown that P301L mutant Tau translocates to dendritic spines ([@bib68]; [@bib23]), has an increased binding affinity towards Fyn in vitro ([@bib3]), and promotes actin polymerization in the presynaptic nerve terminal ([@bib72]). These factors could potentially contribute to the observed Tau P301L mutant-dependent increased trapping of Fyn in nanodomains in dendritic spines.

For simplicity, we interpreted Fyn mobility in spines with a three-diffusive-state model. The immobile state with the lowest diffusion coefficient is likely to represent Fyn molecules bound to their substrate, the confined state could represent Fyn molecules that are trapped in the nanodomains, and the free state may represent Fyn molecules that are moving between synaptic and extrasynaptic compartments. Interestingly, a recent study reported that CaMKII also displays at least three motion states within spines, and that NMDA receptor stimulation immobilizes CaMKII in spines ([@bib48]). It therefore appears that the mobility patterns of signaling molecules such as CaMKII and Fyn could represent the activational state of the underlying signaling network. Investigating synaptic-activity-dependent changes in the mobility patterns of key signaling molecules could potentially unravel the biochemical signaling principles underlying synaptic function.

We found that Fyn forms nanodomains of \~170 nm in diameter within dendritic spines, which are similar to those described for PSD-95 ([@bib52]). Fyn and PSD-95 interact on the plasma membrane following the palmitoylation of specific residues ([@bib59]; [@bib61]; [@bib62]), and act as a hub for multiple other proteins in dendritic spines. Fyn nanoclusters resemble those formed by PSD-95, which are larger than those formed by AMPA receptors ([@bib52]). Further, we found that Fyn forms, on average, one nanodomain per spine, which is similar to the frequency of nanodomains formed by PSD-95 ([@bib26]). As PSD-95 nanoclusters are remodeled during synaptic plasticity ([@bib26]), it would be interesting in the future to assess whether PSD-95 and Fyn are part of the same synaptic complex regulated during synaptic plasticity.

Other factors could potentially influence Fyn nanoclustering in dendrites. A recent study found that, by recruiting GluA1-containing AMPA receptors (AMPARs), netrin-1 regulates spine maturation in hippocampal neurons ([@bib17]). Given that netrin-1 activates Fyn to regulate axon growth and guidance ([@bib49]), it is possible that netrin-1 also contributes to spine maturation via Fyn clustering and signaling. Similarly, Semaphorin3A promotes the maturation of spines in cortical neurons through Fyn signaling ([@bib51]) and could also influence Fyn nanoclustering during maturation. Whether extracellular cues such as netrin-1 and Semaphorin3A mediate spine maturation through Fyn nanoscale reorganization remains to be determined. Previous cell culture studies have shown that the mobility of other postsynaptic proteins, such as the AMPARs ([@bib24]) and Neuroligin-1 ([@bib6]), decreases and that the NMDAR nanodomain area changes with neuronal maturation ([@bib38]). The nanoscale reorganization of postsynaptic proteins therefore appears to be a common feature associated with spine maturation, which could stem from a number of factors pertaining to the spatial trapping of key molecules that are essential for synapse formation and function. Given that the maturation of hippocampal neurons from Tau KO mice is delayed in cell culture ([@bib14]), it would be interesting to determine how Tau and Fyn interact to generate the appropriate signals that are required for dendritic spine formation and maturation ([@bib51]).

Although our results reveal that dendritic spines exhibit significantly lower Fyn mobility than dendritic shafts, we were able to detect Fyn nanodomains in shafts. Recently, the presence of gephyrin clusters in dendritic shafts was found to affect the stability of nearby spines ([@bib27]). It is therefore tempting to speculate that Fyn nanodomains may have a similar functional role in this compartment. One possibility is that these nanodomains contribute to the generation of new spines ([@bib51]). Alternatively, they may act as an extrasynaptic reservoir of Fyn. We also detected Fyn nanodomains at the base of dendritic spines, and a recent study found that AMPAR nanodomains at the base of spines can prevent the movement of AMPARs from the shaft to the spines ([@bib25]). It is conceivable that similar Fyn nanodomains at the base of spines regulate the exchange of Fyn between synaptic and extrasynaptic regions. Alternatively, these Fyn nanodomains may assume other signaling roles or could represent a remnant of cytoskeletal remodeling at this site.

The fact that Tau interacts with Fyn ([@bib42]; [@bib3]) could underpin some of the nanoclustering properties of Fyn, but how Tau affects Fyn organization in the dendritic shaft is currently not understood. Tau has been shown to bind to microtubules, and its dynamic properties have been elegantly described at a single-molecule level ([@bib31]); however, whether Tau itself is organized in nanodomains is currently unknown. Further work is therefore needed to understand the nanoscale organization of Tau and its physiological and pathological implications.

In summary, our study demonstrates that Fyn is organized into specific nanodomains that are dynamically controlled by Tau in dendrites. Tau plays a pivotal role in controlling the nanoscale organization of Fyn molecules. Importantly, mutations of Tau that are associated with the development of frontotemporal dementia have major effects, inducing aberrant trapping of Fyn in spines, which may contribute to the development of the pathology. Fyn is therefore a putative new target for the pathological effects elicited by Tau FTD mutations.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                               Designation                  Source or reference                                               Identifiers                                                    Additional\
  (species) or resource                                                                                                                                                                                     information
  ------------------------------------------- ---------------------------- ----------------------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------------------
  Strain, strain background (*M. musculus*)   C57B1/6                      Jackson Laboratory                                                Cat. \#000664                                                  NA

  Genetic reagent (*M. musculus*)             Tau KO (*Mapt*^--/--^)       Jackson Laboratory\                                               Cat. \#007251                                                  Prof. Michael Vitek (Duke University Medical Center)
                                                                           ([@bib14])                                                                                                                       

  Antibody                                    Rabbit anti-Fyn              Cell Signalling Technologies                                      Cat. \#4023                                                    IF (1:500)

  Antibody                                    Mouse anti-PSD-95            Merck Millipore                                                   Cat. \#MABN68                                                  IF (1:500)

  Antibody                                    Chicken anti MAP2            Merck Millipore                                                   Cat. \#AB15452                                                 IF (1:500)

  Recombinant DNA reagent                     mCardinal-N1                 Addgene                                                           Cat. \#54590                                                   

  Recombinant DNA reagent                     pEGFP-N1                     Clontech/NovoPro                                                  Cat. \#V12021                                                  

  Recombinant DNA reagent                     Fyn-mEos2                    This paper                                                                                                                       

  Recombinant DNA reagent                     Tau-GFP                      PMID: [27378256](https://www.ncbi.nlm.nih.gov/pubmed/27378256/)                                                                  Prof. Jürgen Götz (Queensland Brain Institute, University of Queensland)

  Recombinant DNA reagent                     Tau-P301L-GFP                PMID: [27378256](https://www.ncbi.nlm.nih.gov/pubmed/27378256/)                                                                  Prof. Jürgen Götz (Queensland Brain Institute, University of Queensland)

  Recombinant DNA reagent                     ΔTau-GFP                     [@bib13]                                                                                                                         Prof. Jürgen Götz (Queensland Brain Institute, University of Queensland)

  Chemical compound, drug                     Phalloidin-Alexa Fluor 647   NEB                                                               Cat. \#8940S                                                   IF (1:100)

  Software, algorithm                         Fiji-ImageJ                  ImageJ (<http://imagej.nih.gov/ij/>)                              RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)   Version 2.0.0-rc-68/1.52e

  Software, algorithm                         Neurolucida                  MBF Bioscience                                                    RRID:[SCR_001775](https://scicrunch.org/resolver/SCR_001775)   

  Software,\                                  Huygens software             Scientific Volume Imaging                                         RRID:[SCR_014237](https://scicrunch.org/resolver/SCR_014237)   
  algorithm                                                                                                                                                                                                 

  Software, algorithm                         Metamorph software           Molecular Devices (<https://www.moleculardevices.com>)            RRID:[SCR_002368](https://scicrunch.org/resolver/SCR_002368)   Version 7.7.8

  Software, algorithm                         PALMTracer                   <http://www.iins.u-bordeaux.fr/team-sibarita-PALMTracer>                                                                         

  Software, algorithm                         SR-Tesseler                  [@bib44]\                                                                                                                        
                                                                           (<http://www.iins.u-bordeaux.fr/team-sibarita-SR-Tesseler>)                                                                      

  Software, algorithm                         SharpViSu                    [@bib1]\                                                                                                                         
                                                                           (<https://github.com/andronovl/SharpViSu>)                                                                                       

  Software, algorithm                         DC-MSS                       [@bib66]\                                                                                                                        
                                                                           (<https://github.com/kjaqaman/DC-MSS>)                                                                                           

  Software,\                                  Graphpad Prism               GraphPad Prism (<https://graphpad.com>)                           RRID:[SCR_015807](https://scicrunch.org/resolver/SCR_015807)   Version 7.0d
  algorithm                                                                                                                                                                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animal ethics and mouse strains {#s4-1}
-------------------------------

All experimental procedures were conducted under the guidelines of the Australian Code of Practice for the Care and Use of Animals for Scientific purposes and were approved by the University of Queensland Animal Ethics Committee (QBI/412/14/NHMRC; QBI/027/12/NHMRC; QBI/254/16/NHMRC). Mice were maintained in a 12-hr light/dark cycle and housed in a PC2 facility with *ad libitum* access to food and water. Wildtype mice (C57Bl/6 strain) and Tau KO (*Mapt*^--/--^) mice on a C57Bl/6 background ([@bib14]) were used throughout the study. Tau KO has a loss of function of the *Mapt* gene.

Primary hippocampal cultures {#s4-2}
----------------------------

Embryonic day (E)16 hippocampal neurons were obtained from wildtype and Tau KO mice ([@bib14]) and prepared as described previously ([@bib33]). Briefly, for live-cell super-resolution microscopy, 100,000 neurons were plated onto poly-L-lysine-coated 35 mm glass-bottom dishes (In Vitro Scientific). For immunocytochemistry, 80,000 cells/well were plated onto poly-L-lysine-coated 10 mm diameter coverslips (ProSciTech) in a 12-well plate ([@bib15]). The neurons were cultured in Neurobasal medium (Gibco) supplemented with 5% fetal bovine serum (Hyclone), 2 mM Glutamax (Gibco) and 50 U/mL penicillin/streptomycin (Invitrogen). The medium was changed to serum-free Neurobasal medium supplemented with 2% B27 (Gibco) 4 hr post-seeding, and half the medium was changed every week.

Immunocytochemistry {#s4-3}
-------------------

Primary hippocampal neurons were fixed with 4% paraformaldehyde/4% sucrose for 15 min at room temperature, permeabilized with 0.2% Triton X-100 for 10 min, then blocked for 1 hr in 5% goat serum, followed by primary antibody incubation overnight at 4°C and secondary antibody incubation for 1 hr at room temperature. The following primary antibodies were used: Fyn (Cell Signalling Technologies \#4023; rabbit polyclonal, 1:500), PSD-95 (Millipore, monoclonal, 1:500), MAP2 (Millipore, chicken polyclonal, 1:500), and phalloidin-Alexa Fluor 647 (NEB, 1:100), which was used to detect actin. As secondary antibodies, we used Alexa-Fluor-488-labeled goat-anti-rabbit antibody, Alexa-Fluor-555-labeled goat anti-mouse antibody and Alexa-Fluor-647-labeled goat anti-chicken antibody (all from LifeTechnologies, Thermo Fisher, 1:500). Fluorescence images were captured with a 20X or a 60X objective on a Zeiss LSM710 confocal microscope and analyzed with Fiji-ImageJ software ([@bib60]).

Cloning {#s4-4}
-------

Fyn-mEos2 (human Fyn with carboxy-terminal mEos2 tag) was subcloned from a Fyn-pGEM-T Easy plasmid (human full-length Fyn, isoform 1) by ApaI/SalI double digestion and ligated into the pEGFP-N1 (Clontech) and mEos2-N1 (Addgene \#54662) vector.

Super-resolution microscopy with oblique illumination {#s4-5}
-----------------------------------------------------

Primary neurons were transfected using Lipo2000 and used for super-resolution microscopy 5--7 days post-transfection. The following constructs were used for transfection: Fyn-mEos2, mCardinal-N1 (Addgene \#54590), Tau-EGFP (human Tau with carboxy-terminal EGFP tag) ([@bib68]), ΔTau-EGFP (human Tau lacking the last 186 amino acids, with a carboxy-terminal EGFP tag) and Tau-P301L-EGFP (human mutated Tau-P301L with a carboxy-terminal EGFP tag) ([@bib68]). For live-cell super-resolution microscopy with oblique illumination, Fyn-mEos2-transfected neurons were bathed in imaging buffer (145 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl~2~, 0.5 mM MgCl~2~, 5.6 mM D-glucose, 0.5 mM ascorbic acid, 0.1% BSA, 15 mM HEPES, pH 7.4). Neurons were visualized at 37°C on a Roper Scientific TIRF microscope equipped with an ILas^2^ double laser illuminator (Roper Scientific), a Nikon CFI Apo TIRF 100×/1.49 N.A. objective (Nikon Instrument), an Evolve512 delta EMCCD camera (Photometrics) and a perfect focus system, allowing acquisitions in oblique illumination. Image acquisition was performed using Metamorph software (version 7.7.8, Molecular Devices).

3D analysis of sptPALM trajectories {#s4-6}
-----------------------------------

The multi-dimensional acquisition Z-series App from Metamorph software was used to obtain a z-stack acquisition (each frame every 0.1 μm) of the epifluorescence signal corresponding to the pEGFP fluorophore of hippocampal neurons (DIV20-22) expressing Fyn-mEos2 and pEGFP. sptPALM imaging of the same neuronal segment was performed immediately after the stack acquisition. Z-stack images were deconvolved using Huygens software (Scientific Volume Imaging). 2D maximum intensity projection was performed using Fiji-ImageJ software ([@bib60]). 3D analysis of the dendritic architecture was performed using Neurolucida software (MBF Bioscience). Only spines protruding from the sides of the dendrite branch were considered in this analysis. The shaft region was selected by excluding shaft segments containing spines projecting away from the imaging plane. sptPALM trajectories from spines or shafts were selected for further analysis.

Single-particle tracking photoactivated localization microscopy (sptPALM) {#s4-7}
-------------------------------------------------------------------------

Time-lapse movies were acquired at 50 Hz (16,000 frames) at 37°C. For sptPALM, a 405-nm laser was used to photo-activate the cells expressing Fyn-mEos2 and a 561-nm laser was used simultaneously for excitation of the resulting photo-converted single molecules. To isolate the mEos2 signal from auto-fluorescence and background signals, a double-beam splitter (LF488/561-A-000, Semrock) and a double-band emitter (FF01-523/610-25, Semrock) were used. To spatially distinguish and temporally separate the stochastically activated molecules during acquisition, the respective power of the lasers was adjusted. The 405-nm laser was used between 1.5% and 3% of the initial laser power (100 mW Vortran Laser Technology), and the 561-nm laser was used at 70% of the initial laser power (150 mW Cobolt Jive). 

Single-particle trajectory analysis {#s4-8}
-----------------------------------

The localization and tracking of single molecules were performed as previously described ([@bib52]). Briefly, single-molecule localizations were detected using a wavelet-based segmentation, and trajectories were computed using a simulated annealing-based tracking algorithm ([@bib30]) with PALM-Tracer, software that operates with Metamorph (Molecular Devices) ([@bib52]; [@bib37]). Trajectories that lasted at least eight frames were reconstructed and the mean square displacement (MSD) was computed for each trajectory. Cells with at least 1000 trajectories were considered for further analysis. The MSD was fitted by the equation $MSD\left( t \right) = a + \ 4Dt,$ where D is the diffusion coefficient, a is the y-intercept and t is the time. We considered trajectories with Log~10~\[D\]≤−1.6 as immobile ([@bib2]; [@bib12]; [@bib35]) and computed the immobile fraction from the distribution of the diffusion coefficient histograms for statistical comparisons. The moment scaling spectrum (MSS) analysis was applied to Fyn trajectories that lasted for at least 20 frames, as described previously ([@bib66]).

SR-Tesseler analysis {#s4-9}
--------------------

Fyn nanodomains were quantified from sptPALM data using SR-Tesseler analysis ([@bib44]). Briefly, the coordinates of single-molecule localizations were used to construct a Voronoï diagram, which segmented the sptPALM data into polygons centered on individual localizations. Object segmentation then provided the neuronal contour. We then identified potential Fyn nanodomains as regions within the neuronal contour that contained at least 50 detections and had a local density at least two-fold greater than the average density of the identified object. The nanodomain diameter was calculated using principal component analysis and the area was determined from the segmented cluster outline, as described previously ([@bib44]). A cross-correlation-based drift correction of the sptPALM data was performed using the SharpViSu tool ([@bib1]) before performing SR-Tesseler analysis.

Step-length analysis {#s4-10}
--------------------

We estimated the diffusion coefficients and the occupancies of multiple kinetic states by analyzing the cumulative distribution function (CDF) of displacements of Fyn-mEos2 molecules at 20 ms intervals. To avoid bias resulting from long trajectories ([@bib7]), we computed the CDF of each cell by including only the first seven displacements of each trajectory, which is the minimum trajectory length considered in all our of analyses. The CDF was then fitted with a three-state model given by:$$C\left( {r,\mathrm{\Delta}t} \right) = 1 - f_{1}exp\left( \frac{- r^{2}}{4D_{1}\mathrm{\Delta}t} \right) - f_{2}exp\left( \frac{- r^{2}}{4D_{2}\mathrm{\Delta}t} \right) - f_{3}exp\left( \frac{- r^{2}}{4D_{3}\mathrm{\Delta}t} \right)$$

Here, r is the displacement, Δt is the time interval (20 ms), D~1~, D~2~ and D~3~ are the diffusion coefficients of the three states, and f~1~, f~2~ and f~3~ are the state occupancies. We computed the empirical CDF using the tool ECDF and fit the model predictions to the data using the non-linear regression tool NLINFIT in Matlab to estimate the model parameters. We performed global fitting for each condition by keeping the diffusion coefficients of each state constant across cells and allowing the state occupancies to vary across cells. This was necessary to estimate the parameters reliably.

Statistics {#s4-11}
----------

The D'Agostino and Pearson test was used to test for normality. The Student's *t*-test was used when the data were normally distributed, and the non-parametric Mann Whitney U test was used when the data were not normally distributed. For data sets that compared more than two groups, an ANOVA was used with corrections for multiple comparisons. Statistical comparisons were performed on a per-cell basis, with neurons collected from at least three independent transfection experiments. Unless otherwise stated, values are represented as the mean ± SEM. The tests used are indicated in the respective figure legends. Data were considered significant at p\<0.05. Statistical tests were performed and figures were made using GraphPad Prism 7. A summary of statistical analyses is provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in dendritic spines\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation overseen by Huda Zoghbi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Dezhi Liao (Reviewer \#2).

The reviewers discussed the reviews with one another and the Reviewing Editor drafted this decision to help you prepare a revised submission.

Summary:

Using cultured hippocampal neurons and an elegant adaptation of super-resolution microscopy along with image analyses (sptPALM), this study reveals that Fyn in dendrites forms discrete dynamic nanoscale domains whose mobility/localization alters with neuronal development. Results in this well done study are solid and novel in that they are the first sptPALM study of Fyn dynamics in dendrites.

Essential revisions:

Tau proteins lacking the P301L mutation that are mis-sorted to spines (i.e., truncated tau) need to be tested, see Zhao et al., 2016. A truncated tau experiment would provide more information (the role of microtubule/actin binding). In addition, since Fyn did not need tau to be clustered in spines, it is puzzling why tau P301L would have an effect in spines. There was not enough discussion of this result, which was presented in 2 out of 7 figures.

Finally, data comparing the level of Fyn-GFP in WT vs. tau^-/-^ mice in dendrites would need to be controlled by data showing comparable levels of Fyn-GFP expressed in both neurons/cultures. If such data are not available, Figure 4D, E should be deleted.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Huda Zoghbi as the Senior Editor and a Reviewing Editor.

The manuscript has been improved but there is a remaining issue that needs to be addressed before acceptance, as outlined below:

Given the importance of the newly added ΔTau data, the figure in which these data are presented should be moved from supplementary data to a figure in the main text.

10.7554/eLife.45040.018

Author response

> Essential revisions:
>
> Tau proteins lacking the P301L mutation that are mis-sorted to spines (i.e., truncated tau) need to be tested, see Zhao et al., 2016. A truncated tau experiment would provide more information (the role of microtubule/actin binding). In addition, since Fyn did not need tau to be clustered in spines, it is puzzling why tau P301L would have an effect in spines. There was not enough discussion of this result, which was presented in 2 out of 7 figures.

We appreciate this suggestion and have now performed new experiments with Tau lacking microtubule-binding domain (ΔTau; Cummins et al., 2019) to address how Tau mislocalization to dendritic spines affects the mobility and nanoscale organization of Fyn. We first observed in Tau^(−/−)^ neurons expressing ΔTau-GFP that ΔTau mislocalizes to dendritic spines (Figure 7---figure supplement 1A). Interestingly, we found that the mobility of Fyn-mEos2.1 in the dendrites and spines of Tau^(−/−)^ neurons expressing ΔTau-GFP was similar to those expressing TauWT-GFP (Figure 7---figure supplement 1B-M), suggesting that other mechanisms in addition to the mislocalization of TauP301L to spines are involved in TauP301L-mediated changes in the mobility and organization of Fyn in the dendrites and spines. As suggested, in the fourth paragraph of the Discussion, we discuss the potential factors contributing to P301L mutant Tau-dependent increase of Fyn trapping in spines. We discuss our data in the context of that of Zhao and colleagues (Zhao et al., 2016).

> Finally, data comparing the level of Fyn-GFP in WT vs. tau^-/-^ mice in dendrites would need to be controlled by data showing comparable levels of Fyn-GFP expressed in both neurons/cultures. If such data are not available, Figure 4D, E should be deleted.

Following the reviewer's suggestion, we have now removed Figure 4D, E and the relevant text.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there is a remaining issue that needs to be addressed before acceptance, as outlined below:
>
> Given the importance of the newly added ΔTau data, the figure in which these data are presented should be moved from supplementary data to a figure in the main text.

As requested, we have moved the figure describing the effect of ΔTau from the supplementary (Figure 7---figure supplement 1 in the previous version) to a figure in the main text (Figure 8 in the revised version). We once again thank the editors and reviewers for their constructive comments, which helped improve our manuscript.

[^1]: These authors contributed equally to this work.
